多瑞医药：拟注销全资子公司西藏晨韵实业有限公司

Group 1 - The core viewpoint of the article is that Duori Pharmaceutical (301075.SZ) has recently dissolved its wholly-owned subsidiary, Tibet Chenyun Industrial Co., Ltd., to enhance asset management efficiency, optimize investment structure, and reduce management costs [1] Group 2 - The dissolution of Tibet Chenyun is part of the company's strategy to streamline operations and improve overall financial performance [1]